Tumor necrosis factor-alpha: specific binding sites in rodent brain and pituitary gland - PubMed (original) (raw)
. 1993 Sep-Oct;4(5):377-81.
Affiliations
- PMID: 8117940
Tumor necrosis factor-alpha: specific binding sites in rodent brain and pituitary gland
D A Wolvers et al. Eur Cytokine Netw. 1993 Sep-Oct.
Abstract
Specific binding sites for TNF-alpha in mouse and rat brain, spleen and pituitary gland have been visualized and characterized, using quantitative autoradiography. Mouse recombinant 125I-TNF-alpha has been used as a radioligand. In the spleen, TNF-alpha binding sites were highly concentrated in the white pulpe of mouse and rat spleen. The IG50, as determined by displacement of radioligand by the unlabelled peptide, was 0.3 x 10(-9) M for both species. In the mouse brain, a weak specific binding was observed on the entire surface of the brain tissue. However, none of the nervous or vascular structures were specifically labelled above this signal. No specific binding was detectable in the rat brain tissue. In sharp contrast, in the anterior lobe of the pituitary gland of both mouse and rat, high concentrations of specific binding sites were detectable. Displacement curves in the mouse pituitary gland revealed the presence of two classes of binding sites with respective IC50 values of 10(-9) and 5 x 10(-11) M. A single class of TNF binding site was demonstrated in the rat with an IC50 of 10(-9) M. The presence of TNF binding sites in the anterior pituitary gland underlines the existence of regulatory pathways between the immune and neuroendocrine system.
Similar articles
- Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
Van Rossum D, Ménard DP, Fournier A, St-Pierre S, Quirion R. Van Rossum D, et al. J Pharmacol Exp Ther. 1994 May;269(2):846-53. J Pharmacol Exp Ther. 1994. PMID: 8182554 - Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R. Dumont Y, et al. Neuropeptides. 2004 Aug;38(4):163-74. doi: 10.1016/j.npep.2004.04.007. Neuropeptides. 2004. PMID: 15337369 - Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes.
Adamson GM, Billings RE. Adamson GM, et al. J Pharmacol Exp Ther. 1994 Apr;269(1):367-73. J Pharmacol Exp Ther. 1994. PMID: 8169842 - Identification and pharmacological characterization of somatostatin receptors in rat lung.
Schloos J, Raulf F, Hoyer D, Bruns C. Schloos J, et al. Br J Pharmacol. 1997 Jul;121(5):963-71. doi: 10.1038/sj.bjp.0701205. Br J Pharmacol. 1997. PMID: 9222554 Free PMC article. - Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha.
Alaaeddine N, DiBattista JA, Pelletier JP, Cloutier JM, Kiansa K, Dupuis M, Martel-Pelletier J. Alaaeddine N, et al. J Rheumatol. 1997 Oct;24(10):1985-94. J Rheumatol. 1997. PMID: 9330943
Cited by
- Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling.
Friedrichsen S, Harper CV, Semprini S, Wilding M, Adamson AD, Spiller DG, Nelson G, Mullins JJ, White MR, Davis JR. Friedrichsen S, et al. Endocrinology. 2006 Feb;147(2):773-81. doi: 10.1210/en.2005-0967. Epub 2005 Oct 27. Endocrinology. 2006. PMID: 16254029 Free PMC article. - Progesterone antagonizes the permissive action of estradiol on tumor necrosis factor-alpha-induced apoptosis of anterior pituitary cells.
Candolfi M, Jaita G, Zaldivar V, Zárate S, Ferrari L, Pisera D, Castro MG, Seilicovich A. Candolfi M, et al. Endocrinology. 2005 Feb;146(2):736-43. doi: 10.1210/en.2004-1276. Epub 2004 Nov 4. Endocrinology. 2005. PMID: 15528300 Free PMC article. - Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury.
Sullivan PG, Bruce-Keller AJ, Rabchevsky AG, Christakos S, Clair DK, Mattson MP, Scheff SW. Sullivan PG, et al. J Neurosci. 1999 Aug 1;19(15):6248-56. doi: 10.1523/JNEUROSCI.19-15-06248.1999. J Neurosci. 1999. PMID: 10414954 Free PMC article. - Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures.
Bernardino L, Xapelli S, Silva AP, Jakobsen B, Poulsen FR, Oliveira CR, Vezzani A, Malva JO, Zimmer J. Bernardino L, et al. J Neurosci. 2005 Jul 20;25(29):6734-44. doi: 10.1523/JNEUROSCI.1510-05.2005. J Neurosci. 2005. PMID: 16033883 Free PMC article. - Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.
Silverman MN, Pearce BD, Biron CA, Miller AH. Silverman MN, et al. Viral Immunol. 2005;18(1):41-78. doi: 10.1089/vim.2005.18.41. Viral Immunol. 2005. PMID: 15802953 Free PMC article. Review.